| Dr John Gregory Bentley, MD | |
|
45 Reade Pl, Poughkeepsie, NY 12601-3947 | |
| (203) 739-6662 | |
| Not Available |
| Full Name | Dr John Gregory Bentley |
|---|---|
| Gender | Male |
| Speciality | Pain Medicine - Pain Medicine |
| Location | 45 Reade Pl, Poughkeepsie, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780628198 | NPI | - | NPPES |
| 13114G | Other | NC | BLUE CROSS/BLUE SHIELD |
| 891414G | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0000X | Pain Medicine - Pain Medicine | 200200493 (North Carolina) | Primary |
| Entity Name | Private Diagnostic Clinic Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457389033 PECOS PAC ID: 1355254368 Enrollment ID: O20031204000577 |
News Archive
A team of computer scientists from the University of Delaware and Georgetown University has developed a new system to rapidly determine which cancer drugs are likely to work best given a patient's genetic markers.
In a guest post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy and advocacy officer at PATH, "writes about the important role U.S. agencies play in advancing global health technologies."
The interdisciplinary study examined the influence of two different types of BCI on the brains of test subjects with no prior experience of this technology.
Speaker Nancy Pelosi (D-Calif.) at least did not support or endorse the Grayson remark and called on all miscreants to apologize. She is right — but we deserve more from the Speaker than a response that if one apologizes, all should apologize.
arGEN-X BV, a biopharmaceutical company focused on the discovery and development of human antibodies using its proprietary SIMPLE Antibody platform, today announced the successful first closing of its Series A equity financing round. The Company raised EUR 9.5million (~ USD 13.6 million) from a syndicate of leading life science investors. The financing round is one of the largest of its kind in the last 12 months.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Gregory Bentley, MD 45 Reade Pl, Poughkeepsie, NY 12601-3947 Ph: () - | Dr John Gregory Bentley, MD 45 Reade Pl, Poughkeepsie, NY 12601-3947 Ph: (203) 739-6662 |
News Archive
A team of computer scientists from the University of Delaware and Georgetown University has developed a new system to rapidly determine which cancer drugs are likely to work best given a patient's genetic markers.
In a guest post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy and advocacy officer at PATH, "writes about the important role U.S. agencies play in advancing global health technologies."
The interdisciplinary study examined the influence of two different types of BCI on the brains of test subjects with no prior experience of this technology.
Speaker Nancy Pelosi (D-Calif.) at least did not support or endorse the Grayson remark and called on all miscreants to apologize. She is right — but we deserve more from the Speaker than a response that if one apologizes, all should apologize.
arGEN-X BV, a biopharmaceutical company focused on the discovery and development of human antibodies using its proprietary SIMPLE Antibody platform, today announced the successful first closing of its Series A equity financing round. The Company raised EUR 9.5million (~ USD 13.6 million) from a syndicate of leading life science investors. The financing round is one of the largest of its kind in the last 12 months.
› Verified 4 days ago